Phase II - Development of a Prophylactic Onchocerciasis Vaccine
$2,961,685N44FY2019AINIH
Pai Life Sciences, Inc., Seattle WA
Investigators
Abstract
To develop a vaccine for onchocerciasis to be used for disease control and elimination.
View original record on NIH RePORTER →